OncoMed Pharma Stock Price (NASDAQ:OMED)

Add to My Stocks
$9.2 $0.03 (0.33%) OMED stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
OMED
OncoMed Pharma
24 MAR 2017
amigobulls logo
OMED hand_up
OMED vs S&P 500
Closing Price: Mar 24, 2017
OMED
$9.2 ( 0.33%)
S&P 500
2344 ( -0.08%)
OMED
52 Week Price Range
1 Year Return: -6.24%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-409.7%
home image
Rating
OMED POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

OncoMed Pharma Snapshot Video

12 5 2

OMED Stock Details

Prev Close* : $9.17
Market Cap:
$344.06M
Day Low: $9.07
52 Week Low: $7.41
Open: $9.2
Volume: 236582
Day High: $9.39
52 Week High: $15.49
Dividend:
N/A

Latest Stock Market News

Latest Articles

OncoMed Pharma News - From Partners

OMED Stockcharts

View OMED PE ratio, PS ratio stocks charts and compare with peers.
OMED Chart
Note: Compare OncoMed Pharma stock price history with the index and industry peers.

OncoMed Pharma Valuation

PS ratio (
price to sales ratio
)
13.57

OMED Industry Peers

Company Price Change (%)
Seres Therapeutics (MCRB)10.830.12 (1.12%)
Agenus (AGEN)3.880.04 (1.02%)
Celgene (CELG)123.380.16 (0.13%)
Eli Lilly (LLY)84.180.24 (0.28%)
Bayer Ag (BAYRY)115.450.72 (0.63%)
Glaxosmithkline (GSK)42.310 (0%)
Verastem (VSTM)1.660.15 (9.93%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Oncomed Pharmaceuticals Inc Stock News - Partner Headlines

OncoMed Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues25.89M39.55M37.77M24.68M31.4M
Net Income-85.4M-50.01M-26.07M-22.23M-15.03M
Total Operating Expense111.45M90.18M61.67M47.04M46.64M
view Oncomed Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets237.88M247.84M333.68M79.76M107.2M
Total Liabilities234.33M171.47M215.56M41.22M47.36M
Shareholders Equity3.55M76.36M118.12M38.54M-122.93M
view Oncomed Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-2.13M-52.32M177.58M-13.22M1.94M
Net Cash From (Used By) Operating Activities-75.13M-84.51M144.54M-33.34M-11.28M
Increase (Decrease) In Prop Plant And Equipment-1.36M-1.77M-0.55M-0.71M-2.24M
view Oncomed Pharmaceuticals Inc cashflow statement

OncoMed Pharma Stock Message Board

An investor needs to spend 9.2 to buy OMED stock, as the closing OncoMed Pharma stock price is 9.2. The total market value as denoted by 342.94M for OncoMed Pharma, is the market value of the company's outstanding shares. OncoMed Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: OncoMed Pharma stock price and OncoMed Pharma share price mean the same thing. 236582 OMED shares were traded yesterday, and OncoMed Pharma stock chart shows that the OMED stock quote hit a day high of 9.39 and day low of 9.07. A dividend is a cash payment from a company's earnings and is distributed among shareholders. OncoMed Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of OMED, view OncoMed Pharma stock price history.